First longevity firm to list in Europe bets on 'major exit'

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

First longevity firm to list in Europe bets on 'major exit'

Eric Leire 1.jpg

It could take years to develop a gene therapy to slow aging, but much less for big pharma to scoop up Genflow Biosciences

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article